Cancers andor malignancies can be treated by administration of a cell cycle checkpoint activator, which is preferably \u03b2-lapachone, or a derivative or analog thereof, combined with an oncogenic kinase modulator, preferably imatinib. In a first step, the preferred embodiment utilizes a combination of C2F6 and argon gases as the etchant gas to preferentially etch portions of the alumna write gap layer. The timer unit reads the waiting time from the storage unit and counts an elapse of the waiting time. Thereafter, input orientation of each scanned image is detected. Ultrasound may also be applied, if desired.